Common Contracts
6 similar Change in Control and Severance Agreement contracts by Loxo Oncology, Inc.
EX-10.18 3 a17-1074_1ex10d18.htm EX-10.18 CHANGE IN CONTROL AND SEVERANCE AGREEMENTChange in Control and Severance Agreement • May 5th, 2020 • Connecticut
This Change in Control and Severance Agreement (this “Agreement”) is entered into by and between [·] (the “Executive”) and Loxo Oncology, Inc., a Delaware corporation (the “Company”), on March 6, 2017 (the “Effective Date”).
AMENDED AND RESTATED CHANGE IN CONTROL AND SEVERANCE AGREEMENTChange in Control and Severance Agreement • January 17th, 2019 • Loxo Oncology, Inc. • Pharmaceutical preparations • Connecticut
This Amended and Restated Change in Control and Severance Agreement (this “Agreement”) is entered into by and between Jacob S. Van Naarden (the “Executive”) and Loxo Oncology, Inc., a Delaware corporation (the “Company”), on June 1, 2018 (the “Effective Date”).
AMENDED AND RESTATED CHANGE IN CONTROL AND SEVERANCE AGREEMENTChange in Control and Severance Agreement • January 17th, 2019 • Loxo Oncology, Inc. • Pharmaceutical preparations • Connecticut
This Amended and Restated Change in Control and Severance Agreement (this “Agreement”) is entered into by and between Jennifer Burstein (the “Executive”) and Loxo Oncology, Inc., a Delaware corporation (the “Company”), on June 1, 2018 (the “Effective Date”).
AMENDED AND RESTATED CHANGE IN CONTROL AND SEVERANCE AGREEMENTChange in Control and Severance Agreement • January 17th, 2019 • Loxo Oncology, Inc. • Pharmaceutical preparations • Connecticut
This Amended and Restated Change in Control and Severance Agreement (this “Agreement”) is entered into by and between Nisha Nanda (the “Executive”) and Loxo Oncology, Inc., a Delaware corporation (the “Company”), on June 1, 2018 (the “Effective Date”).
AMENDED AND RESTATED CHANGE IN CONTROL AND SEVERANCE AGREEMENTChange in Control and Severance Agreement • May 8th, 2018 • Loxo Oncology, Inc. • Pharmaceutical preparations • Connecticut
This Amended and Restated Change in Control and Severance Agreement (this “Agreement”) is entered into by and between (the “Executive”) and Loxo Oncology, Inc., a Delaware corporation (the “Company”), on May , 2018 (the “Effective Date”).
CHANGE IN CONTROL AND SEVERANCE AGREEMENTChange in Control and Severance Agreement • March 7th, 2017 • Loxo Oncology, Inc. • Pharmaceutical preparations • Connecticut
This Change in Control and Severance Agreement (this “Agreement”) is entered into by and between [·] (the “Executive”) and Loxo Oncology, Inc., a Delaware corporation (the “Company”), on March 6, 2017 (the “Effective Date”).
